BOSTON, July 10 (Reuters) - Biotechnology company Tercica Inc. said on Tuesday it has signed an agreement with Genentech Inc. to develop combination products to treat short stature and metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results